I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
A Study to Evaluate NT219 Alone and in Combination With ERBITUX (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer
This is a phase 1/2, multi-center study with an open-label, dose escalation phase followed by a single-arm expansion phase to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of NT219 alone and in combination with ERBITUX (cetuximab) in adults with recurrent and/or metastatic solid tumors.
adenocarcinoma
measurable disease
colorectal adenocarcinoma
metastasis
erbitux
- 0 views
- 19 Feb, 2024